AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2020
Dec 1, 2020
33298_dirs_2020-12-01_cd4d724f-71bf-4c9c-95a1-0f8fd5c6a550.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2020-11-27
Reporting Person: Alvarez Nicholas P (Chief Acquisition Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-27 | Common Stock, par value $0.001 | M | 105288 | $1.15 | Acquired | 109288 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-27 | Options to purchase Common Stock | $1.15 | M | 105288 | Disposed | Common Stock, par value $0.001 (105288) | Direct |
Footnotes
F1: Represents a cashless exercise of outstanding stock options to purchase 120,000 shares of common stock. Mr. Alvarez received 105,288 shares of common stock and surrendered 14,712 shares of common stock underlying the option in payment of the exercise price. The Options were issued to Mr. Alvarez pursuant to the terms of an employment agreement, dated July 26, 2018, by and between Mr. Alvarez and the Issuer.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17